ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,067Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 1017

$1.05M Total Retail Price of All Prescriptions

Rank: 71 out of 1017

1,134 Patients Receiving at Least One Drug in Part D
91% Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Missouri
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 1,134 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 1,134 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 914 874 179 1 4
LEVOTHYROXINE SODIUM 879 828 149 2 2
OMEPRAZOLE 873 823 171 3 5
PRAVASTATIN SODIUM 853 739 176 4 18
LISINOPRIL 852 798 180 5 1
AMLODIPINE BESYLATE 825 790 162 6 3
ATORVASTATIN CALCIUM 744 704 153 7 8
FUROSEMIDE 670 645 131 8 7
GABAPENTIN 527 472 105 9 14
METFORMIN HCL 521 468 102 10 9
GLIMEPIRIDE 488 455 80 11 39
HYDROCODONE-ACETAMINOPHEN 466 363 123 S3 12 6
LOSARTAN POTASSIUM 411 380 84 13 15
TRAMADOL HCL 410 398 113 14 16
CLOPIDOGREL 406 401* 66 15 23
WARFARIN SODIUM 397 392* 58 16 13
HYDROCHLOROTHIAZIDE 386 381* 81 17 11
METOPROLOL TARTRATE 379 361 78 18 10
ATENOLOL 350 327 77 19 22
RANITIDINE HCL 334 296 79 20 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 325 297 70 21 35
CARVEDILOL 306 280 55 22 20
SPIRONOLACTONE 304 293 62 23 54
DONEPEZIL HCL 268 268 41 24 32
ALLOPURINOL 267 267 43 25 29
FLUTICASONE PROPIONATE 266 254 128 26 31
LOSARTAN-HYDROCHLOROTHIAZIDE 261 242 53 27 55
POTASSIUM CHLORIDE 252 247* 54 28 12
METOPROLOL SUCCINATE 238 233* 55 29 19
PREDNISONE 226 209 65 30 41
ZOLPIDEM TARTRATE 224 196 47 31 25
TAMSULOSIN HCL 214 209* 50 32 28
LOVASTATIN 213 198 40 33 24
ALENDRONATE SODIUM 197 192* 43 34 40
MELOXICAM 188 156 60 35 37
PANTOPRAZOLE SODIUM 185 174 33 36 30
OXYBUTYNIN CHLORIDE ER 169 169 29 37 116
CEPHALEXIN 169 164* 116 37 121
CITALOPRAM HBR 168 143 35 39 21
ADVAIR DISKUS 167 162* 34 40 52
JANTOVEN 164 148 23 41 138
ALPRAZOLAM 163 140 49 B 42 17
MIRTAZAPINE 162 157* 34 43 48
TRIAMTERENE-HCTZ 150 145* 29 44 43
DIOVAN 150 145* 17 44 56
FINASTERIDE 150 145* 29 44 72
HYDRALAZINE HCL 144 133 23 47 69
TRAZODONE HCL 143 131 29 48 34
AZITHROMYCIN 141 127 106 49 50
PROPRANOLOL HCL 136 136 21 50 111
METHYLPREDNISOLONE 136 131* 97 50 103
TIZANIDINE HCL 134 129* 35 52 112
ESCITALOPRAM OXALATE 131 126* 27 53 46
MONTELUKAST SODIUM 127 122* 24 54 49
AMLODIPINE BESYLATE-BENAZEPRIL 124 119* 26 55 132
NAPROXEN 123 111 57 56 76
OXYBUTYNIN CHLORIDE 122 117* 30 57 95
KLOR-CON M20 120 104 25 58 77
OXYCODONE-ACETAMINOPHEN 119 114* 26 S2 59 84
SERTRALINE HCL 119 119 22 59 26
LANTUS 115 110* 26 61 53
ISOSORBIDE MONONITRATE ER 110 99 20 62 47
GLIPIZIDE 110 105* 22 62 57
TRAMADOL HCL-ACETAMINOPHEN 108 85 28 64 180
KLOR-CON 10 102 97* 26 65 81
NABUMETONE 100 95* 33 66 204
PAROXETINE HCL 99 94* 21 67 67
TORSEMIDE 96 96 14 68 136
VENLAFAXINE HCL ER 95 90* 17 69 97
PROAIR HFA 92 79 36 70 44
CARBIDOPA-LEVODOPA 91 86* 14 71 107
LEVOFLOXACIN 89 84* 69 72 78
VENTOLIN HFA 87 62 28 73 170
FELODIPINE ER 84 79* 16 74 157
SPIRIVA 83 83 19 75 58
TRIAMCINOLONE ACETONIDE 83 78* 69 75 124
VESICARE 83 83 14 75 127
VALSARTAN-HYDROCHLOROTHIAZIDE 79 74* 14 78 113
CLONAZEPAM 77 62 12 B 79 70
EVISTA 77 77 11 79 139
AMOXICILLIN 77 72* 64 79 115
TERAZOSIN HCL 76 53 16 82 126
BENAZEPRIL HCL 76 76 17 82 91
SULFAMETHOXAZOLE-TRIMETHOPRIM 76 71* 40 82 114
MECLIZINE HCL 75 70* 35 85 168
JANUVIA 75 70* 13 85 71
NIFEDIPINE ER 72 61 14 87 117
CYCLOBENZAPRINE HCL 69 54 29 R 88 68
DILTIAZEM 24HR CD 68 68 14 89 96
PIOGLITAZONE HCL 68 <11 <11 R 89 130
POLYETHYLENE GLYCOL 3350 65 65 26 91 74
CELEBREX 64 64 15 92 80
NAMENDA 63 63 12 93 33
NEXIUM 62 57* 13 94 36
LANTUS SOLOSTAR 62 57* 16 94 73
LORAZEPAM 62 62 21 B 94 42
CYMBALTA 61 49 13 97 45
ATENOLOL-CHLORTHALIDONE 60 48 12 98 240
BUPROPION HCL SR 58 43 12 99 149
CILOSTAZOL 58 <11 <11 99 223
SYNTHROID 57 57 13 101 51
NOVOLIN 70-30 57 <11 <11 101 221
DOXYCYCLINE HYCLATE 57 52* 44 101 144
INSULIN SYRINGE* 55 50* 17 104 153
DIAZEPAM 55 <11 <11 B 104 90
CIPROFLOXACIN HCL 54 54 37 106 66
BUSPIRONE HCL 54 49* 11 106 101
DILTIAZEM ER 53 48* 14 108 158
ENALAPRIL MALEATE 53 <11 <11 108 62
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.